Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

• Autor(es): Ziv, Elad ; Dean, Eric ; Hu, Donglei ; Martino, Alessandro ; Serie, Daniel ; Curtin, Karen ; Campa, Daniele ; Aftab, Blake ; Bracci, Paige ; Buda, Gabriele ; Zhao, Yi ; Caswell-Jin, Jennifer ; Diasio, Robert ; Dumontet, Charles ; Dudziński, Marek ; Fejerman, Laura ; Greenberg, Alexandra ; Huntsman, Scott ; Jamroziak, Krzysztof ; Jurczyszyn, Artur ; Kumar, Shaji ; Atanackovic, Djordje ; Glenn, Martha ; Cannon-Albright, Lisa A ; Jones, Brandt ; Lee, Adam ; Marques, Herlander ; Martin, Thomas ; Martinez-Lopez, Joaquin ; Rajkumar, Vincent ; Sainz, Juan ; Juul Vangsted, Annette ; Watek, Marzena ; Wolf, Jeffrey ; Slager, Susan ; Camp, Nicola J ; Canzian, Federico ; Vachon, Celine
• Data: 2015
• Identificador Persistente: https://hdl.handle.net/1822/62281
• Origem: RepositóriUM - Universidade do Minho
• Tipo de Documento: Outro
• Idioma: Inglês
• Contribuidor(es): Universidade do Minho

Descrição

[Excerpt] In this Article, members of the UCSF cohort who had been alive for longer than two years were inadvertently included in the data presented in Table 3. USCF/old treatments should have 109 patients with a hazard ratio of 3.35 and a P value of 0.00028 instead of the 124 patients with a hazard ratio of 3.37 and a P value of 0.00026. The USCF/new patients should have 187 patients with a hazard ratio of 3.57 and a P value of 0.0007 instead of the 208 patients with a hazard ratio of 3.62 and a P value of 0.0006. [...]